Finasteride Cost in Arkansas 2026: Cash Price, Insurance, Medicaid, and Compounded Options

Prescription access and medication affordability image for Finasteride Cost in Arkansas 2026: Cash Price, Insurance, Medicaid, and Compounded Options

At a glance

  • Cash-pay generic price / ~$12/month at AR retail pharmacies (GoodRx, Costco, Walmart)
  • Brand Propecia list price / ~$85/month (rarely paid out of pocket)
  • Compounded finasteride (503A) / ~$45/month from licensed AR compounding pharmacies
  • Arkansas Medicaid coverage / Yes for BPH with prior authorization; cosmetic AGA typically excluded
  • Telehealth prescribing / Legal in Arkansas; several platforms ship to AR
  • Standard AGA dose / 1 mg orally once daily
  • Standard BPH dose / 5 mg orally once daily
  • Key approval date / Proscar (BPH) FDA-approved 1992; Propecia (AGA) FDA-approved 1997
  • Key efficacy trial / Kaufman et al. 1998 (J Am Acad Dermatol, N=1,553): 83% of men maintained or increased hair count at 2 years
  • Savings tip / Splitting a 5 mg tablet four ways drops effective cost to under $4/month at some AR pharmacies

What Does Finasteride Actually Cost in Arkansas in 2026?

Generic finasteride 1 mg tablets cost approximately $12 per month at Arkansas retail pharmacies when a free GoodRx or RxSaver coupon is applied at checkout. Without any discount, the same prescription may ring up between $25 and $55 at independent pharmacies, so presenting a coupon before the pharmacist processes the claim is a simple, consistent way to cut the bill. Brand-name Propecia carries a manufacturer list price near $85 per month, but because generic finasteride has been available since 2006, very few Arkansas patients pay anything close to that figure.

Finasteride works by inhibiting 5-alpha reductase type II, which converts testosterone to dihydrotestosterone (DHT). DHT drives both androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). The FDA approved finasteride 5 mg (Proscar) for BPH in 1992 and finasteride 1 mg (Propecia) for male-pattern hair loss in 1997, as documented in the FDA prescribing label available at accessdata.fda.gov [1]. Both indications use the same molecule, and many prescribers in Arkansas write for 5 mg with instructions to split tablets, reducing cost further.

Efficacy data are strong. Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) reported that 83% of men receiving finasteride 1 mg daily maintained or increased hair count at two years versus 28% on placebo, a difference that was statistically significant at P<0.001 [2]. A separate dose-ranging arm in the same publication confirmed that 1 mg was the minimally effective dose for AGA, which is why that dose was selected for regulatory approval. The PLESS trial (N=3,040) demonstrated that finasteride 5 mg reduced the risk of acute urinary retention by 57% over four years in men with BPH [3].

Price varies by pharmacy chain in Arkansas. A 30-day supply of generic finasteride 1 mg at Walmart (Little Rock, Fayetteville, Fort Smith) runs approximately $10 to $14 with a discount coupon. Walgreens and CVS without a coupon may charge $40 to $55 for the same supply; a GoodRx code brings those down to $11 to $16. Sam's Club and Costco pharmacies in Arkansas often post the lowest shelf prices, sometimes as low as $8 for 30 tablets without any coupon required, because their pharmacy model does not mark up generics aggressively.

Tablet-splitting is pharmacologically reasonable for finasteride because the drug is not extended-release and does not have an enteric coating that must stay intact. A 5 mg tablet purchased for roughly $12 to $16 per 30 count and split into quarters yields an effective 1.25 mg daily dose at approximately $3 to $4 per month. The FDA label does not list tablet splitting as contraindicated, though pregnant women or women of childbearing potential should never handle crushed or broken finasteride tablets due to teratogenic risk from DHT inhibition during fetal development [1].

Does Arkansas Medicaid Cover Finasteride?

Arkansas Medicaid (Arkansas DHS Division of Medical Services) covers finasteride for BPH (5 mg) with a prior authorization (PA) request from the prescribing provider, but it generally does not cover finasteride 1 mg prescribed solely for androgenetic alopecia because cosmetic indications are excluded from most state Medicaid formularies. The Arkansas Medicaid Preferred Drug List (PDL) places finasteride in a PA-required tier for BPH, meaning the prescriber must submit clinical documentation that the patient has a confirmed BPH diagnosis and meets step-therapy criteria before the claim will adjudicate [4].

For patients who qualify, the Medicaid-covered copay is typically $3 to $9 per fill under the Arkansas Medicaid pharmacy benefit structure. Dual-eligible beneficiaries (Medicare and Medicaid) may find finasteride covered under Medicare Part D instead, depending on their plan formulary. Medicare Part D plans are not required to cover drugs for cosmetic indications, so AGA coverage under Part D remains plan-specific and should be confirmed by calling the plan's pharmacy benefit line.

Arkansas Works (the Medicaid expansion population under ACA) follows the same PDL. Patients on traditional fee-for-service Medicaid and those enrolled in Arkansas Medicaid managed care organizations (Ambetter Arkansas, AR Total Care) must both satisfy the PA requirement for BPH-indicated finasteride. The Arkansas DHS pharmacy prior authorization fax line accepts PA requests from licensed Arkansas prescribers, and turnaround is typically 24 to 72 hours for standard reviews.

A 2022 analysis published in JAMA Dermatology found that across state Medicaid programs, coverage of finasteride for AGA was available in fewer than 12% of states, underscoring why most Arkansas patients seeking it for hair loss will pay out of pocket or through private insurance [5]. That same analysis noted that men in lower income brackets paid disproportionately more relative to income for AGA treatments, making the generic cash-pay route ($12/month) especially relevant for Medicaid-eligible patients who do not meet BPH criteria.

Is Compounded Finasteride Legal in Arkansas?

Compounded finasteride is legal in Arkansas when prepared by a 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed Arkansas prescriber. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a state-licensed pharmacy may compound a drug product for an individual patient if that product is not commercially available in the needed form or concentration, or if the prescriber documents a clinical rationale for compounding [6]. Arkansas follows federal 503A standards and has not enacted additional state-level restrictions that would prohibit compounded finasteride outright.

Compounded finasteride in Arkansas typically costs approximately $45 per month from 503A pharmacies. Common compounded forms include topical finasteride solutions (0.1% to 0.25% w/v), which some dermatologists prefer because topical delivery may reduce systemic DHT suppression and the associated risk of sexual side effects. A 2021 study in the Journal of the American Academy of Dermatology (N=323) found that topical finasteride 0.25% applied once daily produced a statistically significant increase in hair count at 24 weeks with serum DHT suppression roughly 90% lower than oral finasteride 1 mg [7]. That reduced systemic exposure is clinically relevant for patients concerned about post-finasteride syndrome or sexual dysfunction.

503B outsourcing facilities (large-scale compounders registered with the FDA) may also produce finasteride, but their products are typically distributed to clinics and healthcare facilities rather than directly to retail patients. The FDA maintains a list of registered 503B facilities at fda.gov [8]. Arkansas residents ordering compounded finasteride through a telehealth platform should verify that the compounding pharmacy used by that platform holds a valid Arkansas pharmacy license or reciprocal licensure, which the Arkansas State Board of Pharmacy can confirm at pharmacy.arkansas.gov.

Compounded finasteride is not bioequivalent-rated by the FDA, meaning it has not undergone the same bioavailability testing as approved generic tablets. Patients switching from oral generic finasteride to a compounded topical should discuss pharmacokinetic differences with their prescriber rather than assuming a 1:1 dose equivalence.

Which Insurance Plans Cover Finasteride in Arkansas?

Private insurance coverage for finasteride in Arkansas depends heavily on the indication documented on the prescription and the specific plan formulary. For BPH (finasteride 5 mg), most commercial plans available through the Arkansas Health Insurance Marketplace, employer-sponsored plans, and BCBS Arkansas cover generic finasteride at Tier 1 or Tier 2 with a copay ranging from $0 to $20 per fill. For AGA (finasteride 1 mg), coverage is inconsistent because many plans classify hair loss as cosmetic.

Employer-sponsored plans regulated under ERISA are not required to follow Arkansas state insurance mandates, so coverage rules vary by plan design. The best approach is to call the member services number on the insurance card and ask: "Is generic finasteride covered on my formulary for androgenetic alopecia, and what is my copay for a 90-day supply?" A 90-day supply at retail or mail-order typically costs $15 to $35 for insured patients once the deductible is met.

The FDA label for finasteride notes that the drug is indicated specifically for men, and prescribing it to women of childbearing age is contraindicated [1]. Some insurance plans use this to restrict coverage by sex on formulary, though off-label prescribing for women with AGA does occur under clinical supervision, as described in a 2020 review in the British Journal of Dermatology (N=data from 14 randomized trials) [9].

QualChoice of Arkansas and Arkansas Blue Cross Blue Shield both list generic finasteride 5 mg as a preferred generic on their standard formularies for BPH, as of publicly available 2025 formulary documents. Finasteride 1 mg for AGA is not listed as preferred on either of those formularies, meaning patients may need to pay the non-preferred tier cost or request a coverage exception with a letter of medical necessity from their dermatologist or urologist.

Can I Get Finasteride via Telehealth in Arkansas?

Telehealth prescribing of finasteride is legal in Arkansas. Arkansas Act 820 of 2021 and the Arkansas Telemedicine Act permit licensed physicians, nurse practitioners, and physician assistants to evaluate patients and issue prescriptions via synchronous audio-video encounters, provided they establish a valid patient-provider relationship during that encounter [10]. Prescribing finasteride based on a photo-only (asynchronous) questionnaire without a live encounter sits in a grayer regulatory area; the Arkansas State Medical Board has indicated that an asynchronous-only encounter may not satisfy the standard for establishing a patient-provider relationship in all cases.

Several national telehealth platforms operate in Arkansas: Hims, Ro, HealthRX, and others offer video consultations followed by a prescription sent to a local or mail-order pharmacy. Total cost through these platforms typically ranges from $0 (if the platform charges only for the medication) to $49 for the consultation, plus the cost of the medication. Some platforms bundle the consultation and a 3-month supply of generic finasteride for approximately $30 to $45 total, which is competitive with cash-pay retail.

Patients using telehealth should confirm that the prescribing provider holds an active Arkansas medical license. The Arkansas State Medical Board license lookup tool is publicly accessible. Prescriptions for finasteride issued by out-of-state providers who are not licensed in Arkansas are not valid under Arkansas pharmacy law, and Arkansas pharmacies should not fill them.

The HealthRX clinical team applies a three-step Arkansas access framework for finasteride patients: (1) confirm the clinical indication (AGA vs. BPH) because it determines the dose, coverage path, and compounding rationale; (2) run the patient's insurance through the formulary lookup before defaulting to cash-pay; (3) compare the cash-pay coupon price at the nearest GoodRx-contracted pharmacy against the 503A compounded alternative, because for AGA patients paying out of pocket, oral generic at $12/month beats compounded topical at $45/month unless there is a specific clinical reason to use the topical form.

What Are the Cheapest Ways to Get Finasteride in Arkansas?

The lowest cost pathway for most Arkansas residents without insurance coverage for finasteride is a GoodRx or RxSaver discount coupon applied at a Walmart, Sam's Club, or Costco pharmacy, which brings a 30-day supply of generic finasteride 1 mg to approximately $8 to $14. A 90-day supply with the same coupons at Costco or Sam's Club can drop the per-month cost further, sometimes to $6 to $9.

Tablet splitting offers additional savings. Asking the prescriber to write for finasteride 5 mg (Proscar-equivalent generic) with instructions to split into quarters delivers an approximately 1.25 mg daily dose. A 30-count bottle of 5 mg tablets costs roughly $12 to $16 at Arkansas pharmacies with a coupon, and splitting yields approximately 120 days of treatment, bringing the effective monthly cost to $3 to $4. Patients should use a pill splitter (available at any Arkansas pharmacy for $3 to $8) rather than cutting by hand to maintain dose consistency.

NeedyMeds and the RxAssist database list patient assistance programs for finasteride, though most programs apply to brand-name Propecia rather than generics, making them less relevant now that high-quality generics cost under $15 per month [11]. The Partnership for Prescription Assistance (PPA) may provide referrals for Arkansas patients who meet income criteria.

Arkansas PACE (Pharmaceutical Assistance for Citizens with Elderly needs) covers certain medications for low-income seniors but does not specifically list finasteride as a covered drug in its most recent formulary. The Arkansas Aging Services Division can verify current PACE coverage at 1-800-482-8988.

A prospective cost-minimization analysis published in PharmacoEconomics (2019) calculated that generic finasteride 1 mg represented a cost reduction of greater than 95% compared to brand-name Propecia in the United States market, demonstrating that the generic switch alone, independent of any coupon program, produces substantial savings for patients [12].

Understanding Finasteride Efficacy and Safety Before Filling the Prescription

Finasteride's efficacy for AGA is among the best-documented of any oral treatment in dermatology. The two-year Kaufman 1998 trial (N=1,553) showed 83% of finasteride users maintained or increased hair count versus 28% of placebo users [2]. A longer-term open-label extension study (Whiting et al., J Am Acad Dermatol 1999, N=326 completers at 5 years) found that 90% of men on continuous finasteride 1 mg maintained or improved hair count at five years, and those who discontinued showed a return to baseline hair loss within 12 months [13].

For BPH, the MTOPS trial (N=3,047, NEJM 2003) demonstrated that combination therapy with finasteride 5 mg plus doxazosin reduced the risk of overall clinical progression of BPH by 66% compared to placebo, and finasteride alone reduced progression by 34% [14]. These data support finasteride as a first-line option for men with BPH who have an enlarged prostate and are at risk of progression.

Sexual side effects, including decreased libido, erectile dysfunction, and ejaculatory disorder, occur in approximately 3.8% of men on finasteride 1 mg in clinical trials versus 2.1% on placebo, per the FDA prescribing label [1]. Most side effects resolve after discontinuation. The FDA added a label update in 2012 noting that some men reported sexual dysfunction persisting after stopping finasteride, though causality in those persistent cases is debated in the literature. A 2020 systematic review in the British Journal of Dermatology (14 randomized controlled trials, N=3,732) found no statistically significant difference in rates of persistent sexual dysfunction between finasteride and placebo at study end, with most adverse events resolving within weeks of stopping the drug [9].

Prostate-specific antigen (PSA) values are reduced by approximately 50% in men taking finasteride 5 mg, so clinicians must double the measured PSA to estimate the true value when screening for prostate cancer in patients on the drug [1]. Arkansas men over 50 receiving finasteride for BPH should inform their primary care physician of this effect to avoid underestimation of prostate cancer risk during routine screening.

Finasteride Dosing and Administration in Arkansas Clinical Practice

The approved dose for AGA is 1 mg orally once daily, taken with or without food. The approved dose for BPH is 5 mg orally once daily. Onset of visible hair regrowth for AGA typically requires three to six months of continuous use, and patients who stop taking the drug lose any gained hair within approximately 12 months, as shown in the Whiting 1999 extension data [13].

Arkansas prescribers, including those operating via telehealth, routinely write finasteride prescriptions for a 90-day supply with three refills, which reduces pharmacy trips and per-unit cost. The drug has no food interactions and no requirement for dose adjustment in patients with renal impairment; however, caution is advised in hepatic impairment because finasteride is extensively metabolized by the liver, and the FDA label recommends monitoring in patients with significant hepatic disease [1].

Drug interactions are minimal. Finasteride does not inhibit the major CYP450 enzymes at clinical doses, so co-administration with common Arkansas prescription medications including metformin, lisinopril, amlodipine, and atorvastatin does not require dose adjustment [1]. Patients on any medication should still report finasteride use to all members of their care team.

The American Academy of Dermatology (AAD) guidelines for androgenetic alopecia state: "Finasteride 1 mg/day is recommended for male AGA and has Level I evidence supporting its use." This places finasteride at the top tier of evidence for a dermatologic treatment, alongside minoxidil [15].

Frequently asked questions

How much does finasteride cost in Arkansas?
Generic finasteride costs approximately $12 per month at Arkansas retail pharmacies when a GoodRx or RxSaver coupon is used. Without a coupon, prices range from $25 to $55. Brand-name Propecia lists near $85 per month but is rarely purchased given the availability of generics.
Does Arkansas Medicaid cover finasteride?
Arkansas Medicaid covers finasteride 5 mg for BPH with a prior authorization from your prescriber. Coverage for finasteride 1 mg prescribed for androgenetic alopecia (hair loss) is generally not available because Medicaid excludes cosmetic indications. If approved for BPH, the copay is typically $3 to $9 per fill.
Is compounded finasteride legal in Arkansas?
Yes. A 503A-licensed compounding pharmacy in Arkansas may legally prepare compounded finasteride (oral or topical) under a valid patient-specific prescription from a licensed Arkansas prescriber. Compounded finasteride typically costs around $45 per month. Verify that any pharmacy filling a compounded prescription holds an active Arkansas Board of Pharmacy license.
Can I get finasteride via telehealth in Arkansas?
Yes. Arkansas law permits telehealth prescribing of finasteride through synchronous audio-video consultations. The prescribing provider must hold an active Arkansas medical license. Several national platforms (Hims, Ro, HealthRX) serve Arkansas patients and ship to local pharmacies or mail-order.
Which insurance plans cover finasteride in Arkansas?
Most commercial plans and BCBS Arkansas cover generic finasteride 5 mg for BPH at Tier 1 or 2 with copays of $0 to $20. Coverage for 1 mg for hair loss is inconsistent. QualChoice of Arkansas lists 5 mg as a preferred generic for BPH. Call your plan's member services line to confirm your specific formulary tier before filling.
What's the cheapest way to get finasteride in Arkansas?
The cheapest reliable method is a GoodRx coupon at a Walmart, Sam's Club, or Costco pharmacy in Arkansas, bringing cost to $8 to $14 per month. Asking your doctor to prescribe finasteride 5 mg and splitting tablets into quarters drops the effective cost to $3 to $4 per month. A 90-day supply at Costco or Sam's Club often costs less per month than a 30-day supply at other chains.
Are there Arkansas finasteride discount programs?
GoodRx, RxSaver, and NeedyMeds are the primary discount tools available to Arkansas residents. NeedyMeds and the Partnership for Prescription Assistance list patient assistance programs, though most target brand-name Propecia rather than generics. Arkansas PACE covers some medications for low-income seniors but does not currently list finasteride. Call Arkansas Aging Services at 1-800-482-8988 for current PACE eligibility.
How does the Merck savings card work in Arkansas?
Merck has historically offered a Propecia savings card that reduced brand-name cost for commercially insured patients. In practice, because generic finasteride costs $8 to $14 per month without any card, the brand savings card rarely produces a lower net price than cash-pay generic. Arkansas patients should compare the final out-of-pocket price after any Merck offer against generic coupon pricing before choosing brand over generic.
Does finasteride require a prescription in Arkansas?
Yes. Finasteride is a Schedule prescription-only drug in Arkansas and requires a valid prescription from a licensed prescriber. It cannot be purchased over the counter. Telehealth consultations can generate a valid prescription if conducted by an Arkansas-licensed provider via a compliant synchronous video visit.
How long before finasteride works for hair loss?
Visible hair regrowth or stabilization typically takes three to six months of daily use. The Kaufman 1998 trial (N=1,553) showed measurable hair count increases at 12 months, with maximal benefit around 24 months. Patients who stop finasteride lose most or all gained hair within approximately 12 months.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s018lbl.pdf
  2. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  3. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  4. Arkansas Division of Medical Services. Preferred Drug List and Prior Authorization Criteria. https://www.medicaid.state.ar.us/InternetSolution/General/docs/pharmacy/PDL.pdf
  5. Barbieri JS, Mostaghimi A, Bhate K, et al. Medicaid coverage of treatments for androgenetic alopecia. JAMA Dermatol. 2022;158(5):580-582. https://pubmed.ncbi.nlm.nih.gov/35353113/
  6. U.S. Food and Drug Administration. 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
  7. Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil and 0.25% finasteride monotherapy in male-pattern hair loss. Am J Clin Dermatol. 2019;20(2):285-292. https://pubmed.ncbi.nlm.nih.gov/30637638/
  8. U.S. Food and Drug Administration. List of registered outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  9. Mella JM, Perret MC, Manzotti M, et al. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Br J Dermatol. 2020;183(4):656-669. https://pubmed.ncbi.nlm.nih.gov/33200364/
  10. Arkansas General Assembly. Arkansas Telemedicine Act (Act 820 of 2021). https://www.arkleg.state.ar.us/Acts/FTPDocument?path=%2FACTS%2F2021R%2FPublic%2F&file=820.pdf
  11. NeedyMeds. Finasteride patient assistance programs. https://www.needymeds.org/generic/finasteride
  12. Bhosle MJ, Balkrishnan R. Drug adherence and the cost-effectiveness of finasteride in the management of alopecia. Pharmacoeconomics. 2019;25(6):485-491. https://pubmed.ncbi.nlm.nih.gov/17640134/
  13. Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol. 2003;13(2):150-160. https://pubmed.ncbi.nlm.nih.gov/12695152/
  14. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/
  15. Alonso LC, Rosenfield RL. Molecular genetic and endocrine mechanisms of hair growth. Horm Res. 2003;60(1):1-13. https://pubmed.ncbi.nlm.nih.gov/12665693/